Literature DB >> 29282686

Perspectives of Reprogramming Breast Cancer Metabolism.

Yi-Ping Wang1, Qun-Ying Lei2.   

Abstract

Reprogramming of cellular metabolism is one of the hallmarks of breast cancer. Breast cancer cells remodel metabolic network to maintain their transformed state and survive in a harsh tumor microenvironment. Dysregulated metabolism further interacts with cellular signaling and epigenetics to promote breast cancer development. Meanwhile, breast cancer stem cells exhibit unique metabolic features, which are critical for therapeutic resistance and tumor recurrence. Besides, aberrant metabolism of breast cancer cells reshapes tumor microenvironment, such as promoting cancer vascularization and sabotaging tumor immunity, to accelerate tumor progression. These special metabolic traits not only open vulnerabilities of breast cancer by targeting essential metabolic pathways but also provide promising diagnostic and prognostic biomarkers to facilitate clinical investigations. Studies in the last few decades have significantly advanced our understanding of mechanisms underlying the reprogramming of breast cancer metabolism and metabolic regulation of breast cancer biology. Targeting tumor metabolism serves as a potentially effective therapeutic approach to suppress breast cancer.

Entities:  

Keywords:  Amino acid metabolism; Breast cancer stem cell; Cancer immunity; Cancer microenvironment; Cell signaling; Fatty acid metabolism; Glycolysis; Metabolic biomarker; Metabolic reprogramming

Mesh:

Year:  2017        PMID: 29282686     DOI: 10.1007/978-981-10-6020-5_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  17 in total

1.  Survival-Associated Metabolic Genes and Risk Scoring System in HER2-Positive Breast Cancer.

Authors:  Chundi Gao; Huayao Li; Chao Zhou; Cun Liu; Jing Zhuang; Lijuan Liu; Changgang Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

2.  Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer.

Authors:  Xu Chang; Peng Xing
Journal:  Lipids Health Dis       Date:  2022-05-13       Impact factor: 4.315

3.  Untargeted Metabolomics of Breast Cancer Cells MCF-7 and SkBr3 Treated With Tamoxifen/Trastuzumab.

Authors:  Basma M Sharaf; Alexander D Giddey; Hasan Alniss; Hamza M Al-Hroub; Raafat El-Awady; Muath Mousa; Ahmed Almehdi; Nelson C Soares; Mohammad H Semreen
Journal:  Cancer Genomics Proteomics       Date:  2022 Jan-Feb       Impact factor: 4.069

Review 4.  Metabolite sensing and signaling in cell metabolism.

Authors:  Yi-Ping Wang; Qun-Ying Lei
Journal:  Signal Transduct Target Ther       Date:  2018-11-09

5.  A new metabolic signature contributes to disease progression and predicts worse survival in melanoma.

Authors:  Mengdi Wan; Binyu Zhuang; Xiao Dai; Liang Zhang; Fangqing Zhao; Yan You
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

6.  Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach.

Authors:  Caridad Díaz; Carmen González-Olmedo; Leticia Díaz-Beltrán; José Camacho; Patricia Mena García; Ariadna Martín-Blázquez; Mónica Fernández-Navarro; Ana Laura Ortega-Granados; Fernando Gálvez-Montosa; Juan Antonio Marchal; Francisca Vicente; José Pérez Del Palacio; Pedro Sánchez-Rovira
Journal:  Mol Oncol       Date:  2022-04-14       Impact factor: 7.449

Review 7.  Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts.

Authors:  Angelica Avagliano; Giuseppina Granato; Maria Rosaria Ruocco; Veronica Romano; Immacolata Belviso; Antonia Carfora; Stefania Montagnani; Alessandro Arcucci
Journal:  Biomed Res Int       Date:  2018-06-05       Impact factor: 3.411

8.  Evaluation of long-chain acyl-coenzyme A synthetase 4 (ACSL4) expression in human breast cancer.

Authors:  Negar Dinarvand; Hossein Khanahmad; Sayyed Mohammadreza Hakimian; Abdolkarim Sheikhi; Bahman Rashidi; Morteza Pourfarzam
Journal:  Res Pharm Sci       Date:  2020-02-20

9.  Esculetin Inhibits Cancer Cell Glycolysis by Binding Tumor PGK2, GPD2, and GPI.

Authors:  Song-Tao Wu; Bo Liu; Zhong-Zhu Ai; Zong-Chao Hong; Peng-Tao You; He-Zhen Wu; Yan-Fang Yang
Journal:  Front Pharmacol       Date:  2020-03-27       Impact factor: 5.810

10.  CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling.

Authors:  Renlun Huang; Shengqi Wang; Neng Wang; Yifeng Zheng; Jianfu Zhou; Bowen Yang; Xuan Wang; Juping Zhang; Lang Guo; Shusheng Wang; Zhiqiang Chen; Zhiyu Wang; Songtao Xiang
Journal:  Cell Death Dis       Date:  2020-04-16       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.